SARS-antibody-80R-(IgG) |
E24CHA001 |
EnoGene |
Human-,-Human-IgG1. |
EUR 276.5 |
Description: Human, Human IgG1. |
Human IgG antibody Laboratories manufactures the anti sars medication reagents distributed by Genprice. The Anti Sars Medication reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Anti products are available in stock. Specificity: Anti Category: Sars Group: Medication
SARS-CoV-2 Human IgG Assay Control |
Genovis AB |
1 mL |
EUR 105 |
Human True insulin ELISA kit |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Medication information
anti-NSP1 (SARS-CoV-2) |
MBS448187-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-NSP2 (SARS-CoV-2) |
MBS448188-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-NSP2 (SARS-CoV-2) |
MBS448188-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-NSP3 (SARS-CoV-2) |
MBS448189-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-NSP3 (SARS-CoV-2) |
MBS448189-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-NSP4 (SARS-CoV-2) |
MBS448190-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-NSP4 (SARS-CoV-2) |
MBS448190-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-NSP5 (SARS-CoV-2) |
MBS448191-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-NSP5 (SARS-CoV-2) |
MBS448191-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-NSP8 (SARS-CoV-2) |
MBS448192-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-NSP8 (SARS-CoV-2) |
MBS448192-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-NSP9 (SARS-CoV-2) |
MBS448193-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-NSP9 (SARS-CoV-2) |
MBS448193-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-NSP7 (SARS-CoV-2) |
MBS448211-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-NSP7 (SARS-CoV-2) |
MBS448211-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-ORF3a (SARS-CoV-2) |
AB0372-100 |
SICGEN |
300 µg |
EUR 352 |
|
Description: ORF3a encodes a viral accessory and uncharacterised protein with possible role in the viral life cycle. Six functional domains have been identified and have linked to infectivity, virulence, ion channel formation and virus release. |
anti-ORF7a (SARS-CoV-2) |
AB0379-100 |
SICGEN |
300 µg |
EUR 352 |
|
Description: ORF7a is a SARS-CoV accessory protein that is composed of a type I transmembrane protein that localizes primarily to the Golgi apparatus and also be found on the cell surface. This protein has been implicated on several mechanisms such as suppressing both transgene and virus-induced gene silencing by reducing the levels of small interfering RNA (siRNA), attachment and modulation of leukocytes by biding to host ITGAL and playing a role as antagonist of host tetherin (BST2) by disrupting its antiviral effect. |